A key event in human population history is the dispersal of early humans from Africa to other parts of the world with different climates, pathogens, sources of food and xenobiotic exposure, and the dynamic adaptation to the evolving environments ([@b23-ehp-117-1541]). Current phenotypic differences between individuals/groups could be due partly to functional polymorphisms that facilitated survival in the ancestral populations ([@b10-ehp-117-1541]). Resolving the underlying allelic architectures of environmental response and searching for their molecular adaptation to selective forces have been attractive indirect strategies for implementation and interpretation of genetic analysis of environmental response and complex disorders ([@b3-ehp-117-1541]; [@b39-ehp-117-1541]).

Members of the cytochrome P450 (CYP) 3A family are among the most important CYP enzymes in humans. They metabolize various endogenous and exogenous chemicals, such as clinically important drugs, environmental carcinogens, cholesterol, steroids, and other lipids ([@b58-ehp-117-1541]). Members of the CYP3A family are expressed in organs primarily associated with xenobiotic and hormone disposition, such as the liver and gastrointestinal tract ([@b58-ehp-117-1541]). Four functional CYP3A enzymes---CYP3A4, CYP3A5, CYP3A7, and CYP3A43---have been identified in humans. CYP3A4 is most abundant in adult liver and intestine and is the major enzyme involved in xenobiotic and drug metabolism ([@b19-ehp-117-1541]). CYP3A5 is the predominant form in the kidney ([@b22-ehp-117-1541]). CYP3A7, a fetoplacental enzyme found only in humans, is expressed mainly in fetal liver ([@b28-ehp-117-1541]) and extrahepatic tissues such as endometrium and placenta ([@b6-ehp-117-1541]; [@b42-ehp-117-1541]). The more recently cloned CYP3A43 is expressed predominantly in prostate and testis ([@b21-ehp-117-1541]). Interindividual variation in CYP3A activity up to 10-fold has been observed ([@b12-ehp-117-1541]). Because CYP3A activity is a major determinant of drug response and may be associated with risk for cancers such as breast and prostate cancer ([@b25-ehp-117-1541]), the identification of sequence variants at the *CYP3A* locus and functional characterization of their clinical relevance have been of long-standing interest in pharmacogenetics and toxicogenetics.

The human *CYP3A* gene cluster resides in a 231-kb region on chromosome 7q22 and consists of four genes and two pseudogenes, arranged in the order of *CYP3A5*, *CYP3A5P1*, *CYP3A7*, *CYP3A5P2*, *CYP3A4*, and *CYP3A43*, from centromere to telo mere ([@b15-ehp-117-1541]) ([Figure 1](#f1-ehp-117-1541){ref-type="fig"}). *CYP3A43* is in the opposite orientation from all other *CYP3A* genes. Each intact gene encodes a protein consisting of 503 amino acids. [@b15-ehp-117-1541] suggested that the locus arose through duplication of an ancestral *CYP3A* cassette of 40--50 kb. Many genetic variants have been identified in this locus and are available online (<http://www.imm.ki.se/CYPalleles/>); some functional variants for *CYP3A* have been reported, such as the *CYP3A5\*3*, which results in an incorrectly spliced mRNA and a truncated nonfunctional protein ([@b26-ehp-117-1541]).

Parallel to exploring phenotypic effects and clinical relevance of *CYP3A* genetic polymorphisms, investigating molecular adaptations to the environment is an intriguing complementary strategy for pharmacogenetic and toxicogenetic studies. The *CYP3A4* and *CYP3A5* genes have a strong haplotype structure at varying frequencies across ethnic groups ([@b52-ehp-117-1541]). Using a comparative genomics approach and sequence-based neutrality test, [@b52-ehp-117-1541] reported evidence of positive selection on the derived allele of the functional *CYP3A5\*3* in non-African populations and significant correlation of its allelic frequency with distance from the equator. In a genotype-based investigation on the *CYP3A* locus, [@b41-ehp-117-1541] proposed that negative natural selection acted primarily toward the elimination in non-African populations of the ancestral *CYP3A4\*1B* allele rather than toward the reduction of CYP3A5 expression described by [@b52-ehp-117-1541]. It should be noted that these population genetics studies were based on a small fraction of sequence information or on only limited data of genotypes of single-nucleotide polymorphisms (SNPs), and both had limited coverage of the 230-kb genomic sequence of *CYP3A* locus. Therefore, the refined molecular targets of natural selection on the complete *CYP3A* locus and its evolutionary dynamics with respect to geographically and temporally fluctuating environments in our demographic history have not yet been explicitly pinpointed.

To further identify genetic variations in the human *CYP3A* locus and assess the effect of natural selection on the pattern of nucleotide diversity at this locus, we resequenced the human *CYP3A* locus in three populations and addressed evolutionary population genetics on the gene cluster.

Materials and Methods
=====================

Subjects and samples
--------------------

We obtained human genomic DNA samples from two sources: *a* ) we extracted genomic DNA samples from venous blood for 29 unrelated healthy Chinese men (average age, 20 ± 2 years) who were chosen from the sample collection constructed for the Chinese Human Genome Diversity Project through a coordinated effort of several institutes ([@b8-ehp-117-1541]); and *b*) we used DNA samples of 24 Caucasians (11 females, 13 males), 24 Africans (9 females, 15 males), and three apes \[i.e., one common chimpanzee (*Pan troglodytes*), one lowland gorilla (*Gorilla gorilla*), and one orangutan (*Pongo pygmaeus*)\] provided by Coriel Cell Repositories (Camden, NJ, USA). Written informed consent was obtained from all the Chinese subjects. This study was performed with the approval of the Ethical Committee of Chinese National Human Genome Center at Beijing.

Sequencing strategy
-------------------

A schematic representation of genes and pseudogenes at the *CYP3A* locus and the resequenced regions is shown in [Figure 1](#f1-ehp-117-1541){ref-type="fig"}. We screened 54 genomic DNA fragments totaling 43,675 bases. The resequenced regions included nearly all exons (except exon 11 of *CYP3A7* because of difficulty in sequencing the highly homologous sequences) and relevant exon--intron boundaries of four genes (*CYP3A43*, *CYP3A4*, *CYP3A7*, and *CYP3A5*) and two pseudogenes (*CYP3AP1* and *CYP3AP2*) and approximately 2.5-kb promoter regions of the four intact genes. We also resequenced four randomly selected segments equally distributed across the *CYP3A43*--*CYP3A4* gene interval and a fragment in *CYP3AP2*--*CYP3A7* interval, with an average length of 1.1 kb.

Identification of polymorphisms and divergences
-----------------------------------------------

We identified polymorphisms by sequencing polymerase chain reaction (PCR) products from both ends. Long-range PCR (L-PCR) amplifications were performed first with primers specific for the target DNA regions to increase specificity \[GenBank accession no. NG_000004.2 ([@b32-ehp-117-1541])\]. DNA sequencing was performed using overlapping primers that covered the overall L-PCR fragments. We confirmed positions and individual genotypes of the variations by resequencing from the opposite strand or from overlapped sequencing. Fixed differences or divergences between humans and apes were inferred by aligning the resequenced sequences of humans with those of the three apes; we considered the alleles that occurred in the apes to be the ancestral alleles for polymorphic sites. Details regarding PCR and sequencing conditions, as well as PCR primers, are available on request. As a measure of quality control, sequence segments of individuals presenting singletons or ambiguous polymorphisms were reamplified and resequenced. We assessed SNP data validity by repeating 10% of the assays. The error rate was relatively low (1.2%).

Data analysis
-------------

We performed tests of fitness to the Hardy-Weinberg equilibrium for each polymorphic site using LDA software ([@b11-ehp-117-1541]). We used the false discovery rate method to correct for multiple testing using Q-VALUE in R (Dabney and Storey 2002) as described by [@b47-ehp-117-1541]. Three measures of nucleotide diversity were assessed: average nucleotide diversity (π), a statistic based on the average number of pairwise sequence differences and influenced mostly by intermediate-frequency variants ([@b50-ehp-117-1541]); Watterson's θ~W~, which is based on the number of segregating sites and influenced mostly by low-frequency variations, theoretically equal to the neutral mutation parameter *4N~e~*m ([@b56-ehp-117-1541]); and θ~H~ ([@b14-ehp-117-1541]), a summary that gives more weight to high frequency--derived alleles. To test whether the frequency spectrum of polymorphisms conformed to the standard neutral model, we calculated the values of four test statistics: Tajima's *D*, which considers the difference between π and θ~W~ ([@b50-ehp-117-1541]); Fu and Li's *F\** and *D\**, which compare the number of singletons with the number of nonsingletons ([@b18-ehp-117-1541]); and Fay and Wu's *H*, which compared the high-frequency with intermediate frequency--derived variants ([@b14-ehp-117-1541]). Significant values for these test statistics were estimated from 10^4^ coalescent simulations of a Wright-Fisher equilibrium model that conditioned on a constant sample size and the level of polymorphism as the observed data ([@b24-ehp-117-1541]). We also performed the Hudson--Kreitman--Aguade (HKA) test to compare the diversity patterns in the sequences observed in our study and those observed in *DMD* intron 44 ([@b31-ehp-117-1541]). All neutrality tests and coalescent simulations were performed using DnaSP software, version 4.0 ([@b38-ehp-117-1541]).

We calculated an unbiased small-sample estimator of pairwise populations *F*~ST~ (F-statistic/fixation index), a measure of allele frequency difference among populations and an estimate of interpopulation genetic differentiation, as described previously ([@b57-ehp-117-1541]). A bootstrapping method (1,000 bootstrap samples) was used to test the statistical significance of *F*~ST~ in each pairwise comparison between populations. Lewontin's D′ and *r*^2^ were applied to evaluate the pairwise linkage disequilibrium (LD) between biallelic polymorphisms. We used Fisher's exact test to determine the statistical significance of pairwise LD, followed by false discovery rate correction for multiple testing. We used GOLD software ([@b7-ehp-117-1541]) as described by [@b1-ehp-117-1541]) to draw the LD maps.

Haplotypes were constructed using the Phase 2.0 program ([@b46-ehp-117-1541]). We then partitioned haplotype blocks with HaploBlockFinder ([@b63-ehp-117-1541]) as described by [@b64-ehp-117-1541]. The mutational relationships among haplotypes in *CYP3A43* and *CYP3A5* were shown by constructing minimum-spanning trees (MSTs), with the common chimpanzee as an out-group species. We calculated the networks by reduced median algorithm for *CYP3A5* and median jointing algorithm for *CYP3A43* implicated in the Network 4.1 package ([@b16-ehp-117-1541]) as described by [@b4-ehp-117-1541].

Results
=======

Data summary and sequence variations
------------------------------------

We sampled 77 unrelated human individuals, including 24 Africans, 24 Europeans, and 29 Asians. The surveyed sequences spanned 43,675 kb and contained almost all of the coding sequences of *CYP3A4*, *CYP3A5*, *CYP3A7*, and *CYP3A43*. We observed a total of 167 segregating sites (including 165 biallelic SNPs and two biallelic indel polymorphisms) in the human DNA samples \[see Supplemental Material, [Table 1](#t1-ehp-117-1541){ref-type="table"}, available online (doi:10.1289/ehp.0800528.S1 via <http://dx.doi.org/>)\], yielding an average density of one SNP per 262 bp. Of the variants identified, 11 were nonsynonymous, 2 resulted in a splicing defect, 1 was a frame shift mutation, and 8were synonymous.

Sequence divergence between human and chimpanzee was 0.95--0.97% for the total locus in subpopulations, which was comparable with the genome-wide average of 1.24% ([@b13-ehp-117-1541]). Nucleotide diversity was low in both Chinese and Caucasians: 1.6 × 10^−4^ and 1.4 × 10^−4^, respectively, for π; 2.8 × 10^−4^ and 3.1 × 10^−4^, respectively, for θ~W~ ([Table 1](#t1-ehp-117-1541){ref-type="table"}). When the *F*~ST~ for three-way population comparisons were estimated with polymorphisms site-by-site, 11 *F*~ST~ values (ranging from 0.30 to 0.50) fell into the upper 0.05 tail of the empirical genomewide distributions estimated previously ([@b5-ehp-117-1541], [@b48-ehp-117-1541]) \[see Supplemental Material, [Table 1](#t1-ehp-117-1541){ref-type="table"} (doi:10.1289/ehp.0800528. S1)\]. Comparison of *F*~ST~ for Africans and non-Africans using the empirical genome-wide *F*~ST~ distribution constructed with similar sets of pooled non-African and African samples ([@b20-ehp-117-1541]) showed that estimated *F*~ST~ values for five variants (T147767C, G164751T, T165611C, A169228G, and A260167G) were extremely high (≥ 0.40; data not shown) and fell above the 95th percentile of the empirical distribution.

Selective neutrality tests
--------------------------

Frequency spectra of the derived alleles for the three populations are shown in [Figure 2](#f2-ehp-117-1541){ref-type="fig"}. Notably, we observed an excess of singletons and nearly fixed SNPs (derived allelic frequencies \> 80%). Consistently, Tajima's *D*, and Fu and Li's *F\** and *D\** deviated significantly from expectations under neutrality in all three populations examined. When individual populations were considered, *D* and *F\** values in both Chinese and Caucasians were significant (*p* \< 0.05), and *D\** was significant in Chinese (*p* \< 0.05). We also observed a statistically significant *H* value in Caucasians (*p* = 0.046). Results of the HKA test indicated that the nucleotide diversity patterns in the entire surveyed sequences were significantly different from those in the neutral *DMD* intron 44 in all three subpopulations (*p* \< 0.05).

We performed sliding-window analyses for the neutrality tests, with each window containing 20 variations and with a step size of one variation. The values of the neutrality statistics varied widely across the locus in all three populations and in subpopulations ([Figure 3](#f3-ehp-117-1541){ref-type="fig"}). We observed significantly negative *D*, *D\**, *F\**, and *H* values simultaneously in two regions in all the three populations. The first region covered the 40.5-kb sequence from the *CYP3A43*--*CYP3A4* interval to *CYP3A4* intron 6, or between SNPs C122872T and T163355G. The second region covered the 25.7-kb sequence from the *CYP3A5P2*--*CYP3A7* interval to *CYP3A7* exon 7, or between SNPs G191479A and A217213G. In addition, significantly negative values for all four test statistics were also observed in the region from *CYP3A43* intron 10 to *CYP3A43* 5′-flank region (between SNPs A73018G and G106490T) in Chinese, and in the region from *CYP3A5* exon 2 to *CYP3A5* 3′ untranslated region (between SNPs C256880T and C284792T) in Caucasians.

Linkage disequilibrium
----------------------

When 24 SNPs shared by all three subpopulations were considered, mean pairwise \|D′\| values were significantly higher in Chinese (*p* = 0.001) and Caucasians (*p* \< 0.001) compared with Africans: values were 0.93, 0.86, and 0.74, respectively. The Africans had far fewer SNP pairs with *r*^2^ ≥ 0.5 compared with either Chinese or Caucasians (6.5%, 25.0%, and 22.8%, respectively). Five SNPs in *CYP3A43* (G83269C, C83448T, A83566G, C83448T, and T88726C) were in complete LD with each other in all three populations. These five SNPs were also in significant LD with both the nonsynonymous substitution *CYP3A43*\**3* and the frame shift mutation *CYP3A43*\**2A* in non-Africans. The patterns of LD structure in each population ([Figure 4](#f4-ehp-117-1541){ref-type="fig"}), delineated with polymorphisms with minor allelic frequency \> 5% in individual populations, also showed remarkable differences in extent and strength of LD across the entire locus between Africans and non-Africans. When the threshold of \|D′\| value was set at 0.8, we observed five, four, and seven LD blocks in Chinese, Caucasians, and Africans, respectively. The longest blocks spanned 60.5 kb in Chinese (block D), 81.7 kb in Caucasians (block B), and 49.3 kb in Africans (block D) ([Figure 4](#f4-ehp-117-1541){ref-type="fig"}).

Haplotype distribution
----------------------

Because all four neutrality tests indicated that nucleo tide diversity patterns in the regions between SNPs A73018G and G106490T in *CYP3A43* and between SNPs C256880T and C284792T in *CYP3A5* deviated significantly from expected under neutrality in non-Africans, we constructed the haplotypes in these regions of *CYP3A43* and *CYP3A5* and depicted their mutational relationships by constructing MSTs rooted with the chimpanzee \[[Figure 5](#f5-ehp-117-1541){ref-type="fig"}; see also Supplemental Material, [Figure 1](#f1-ehp-117-1541){ref-type="fig"} (doi:10.1289/ehp.0800528.S1)\]. The haplotype MSTs showed two clusters of haplotypes for both regions, one main cluster dominated with only one common haplotype ([Figure 5B](#f5-ehp-117-1541){ref-type="fig"}, left) and one minor cluster scattered with haplotypes with low or intermediate frequencies ([Figure 5B](#f5-ehp-117-1541){ref-type="fig"}, right). The haplotype clusters at the *CYP3A43* locus were separated by five nucleotides at positions 83269, 83448, 83566, 83643, and 88726, with high frequency--derived alleles at positions 83448 and 83643 ([Figure 5B](#f5-ehp-117-1541){ref-type="fig"}). The haplotype clusters at the *CYP3A5* locus were separated by two high frequency--derived alleles at positions 260167 and 284792 \[see Supplemental Material, [Figure 1](#f1-ehp-117-1541){ref-type="fig"} (doi:10.1289/ehp.0800528.S1)\]. The haplotype diversity test showed that haplotype diversity in the *CYP3A43* region deviated obviously from that expected under neutrality in Chinese and Caucasians or non-Africans, and haplotype diversity in *CYP3A5* deviated significantly from that expected under neutrality in Caucasians ([Table 2](#t2-ehp-117-1541){ref-type="table"}).

Discussion and Conclusion
=========================

Several lines of evidence indicate signatures of natural selection on *CYP3A4* and *CYP3A7* in all three populations in our study. First of all, we observed extremely low nucleotide diversities at both gene loci in all three populations. The π values were obviously much lower than the genome-wide average for autosomes (7.7 × 10^−4^), across chromosome 7 (7.6 × 10^−4^) ([@b45-ehp-117-1541]), and in coding regions for autosomal genes (3.4 × 10^−4^) ([@b40-ehp-117-1541]). Second, significantly negative values for all four statistics (Tajima's *D*, Fu and Li's *D*\* and *F*\*, and Fay and Wu's *H*) were observed in *CYP3A4* and *CYP3A7*. Third, the HKA test also indicated a local reduction in variability relative to divergence at the *CYP3A* locus compared with the neutral *DMD* intron 44 ([@b31-ehp-117-1541]).

In agreement with our findings, [@b36-ehp-117-1541] also detected particularly strong recent positive selections on protein-coding sequences of human *CYP3A4* and *CYP3A7* after the split of the chimpanzee and human lineages or early in hominoid evolution. In a recent phylogenetic investigation, [@b62-ehp-117-1541] also showed that the Gotoh's substrate recognition sites of human CYP3A is associated with the sites under adaptive evolution. CYP3A is involved in the metabolism of foreign compounds, such as naturally occurring flavonoids, diterpenoids in germander, pyrrolizidine alkaloids (e.g., echimidine and jacobine), and herbal constituents ([@b65-ehp-117-1541]). CYP3A also normally metabolizes food-derived activators of pregnane X receptor and/or constitutive androstane receptor, thereby regulating the expression of a range of detoxifying systems in the liver ([@b53-ehp-117-1541]). Therefore, molecular adaptation to the evolving environment is possible for the *CYP3A* locus or individual genes in this locus.

In the present study, we observed that the 40.5-kb region from the *CYP3A4* 5′-flanking region to *CYP3A4* intron 6 was under a recent positive selection in human samples overall. [@b52-ehp-117-1541] also observed an excess of rare variants, as well as a low number of polymorphisms, in the *CYP3A4* gene in non-Africans but not Africans. [@b41-ehp-117-1541] observed that the region centromeric of the ancestral *CYP3A4\*1B* allele (which is correlated with moderately increased expression of *CYP3A4* mRNA and protein and increased activity) exhibits "high haplotype homozygosity in European Caucasians as oppose d to African Americans." The slight difference between our study and that of [@b52-ehp-117-1541] may be due to differences in data analysis, as all the neutrality tests were performed on the assumption of absence of genetic recombination across the locus. However, recombination at the *CYP3A* locus is possible, as indicated by LD structure in the present study. Neutrality tests that take recombination into account, such as the sliding-window analysis, may be more appropriate. Of course, it is still difficult to pinpoint the evolutionary driving force shaping the nucleotide diversity pattern of *CYP3A4* in our study. In spite of its role in the metabolism of xenobiotics, CYP3A4 also metabolizes endogenous chemicals such as the eicosanoid metabolite endocannabinoid anandamide ([@b44-ehp-117-1541]) and uroporphyrin ([@b17-ehp-117-1541]); factors that lead to fluctuation of these chemicals might be one of selective forces for human *CYP3A4.*

CYP3A7 shows distinctly high catalytic activities for the 16α-hydroxylation of steroids with a C17-keto group, such as estrone ([@b27-ehp-117-1541]) and dehydroepiandrosterone ([@b34-ehp-117-1541]), and plays a role in estriol synthesis ([@b43-ehp-117-1541]) and retinoic acid metabolism ([@b29-ehp-117-1541]). [@b28-ehp-117-1541] observed extremely low expression of CYP3A7 in livers of anencephalic human fetuses. This iso enzyme is supposed to be feto protective in humans. In the present study, we observed that a nonsynonymous substitution of *CYP3A7*, N192S, was driven to near fixation in all human samples and fixed in non-Africans. The N192S SNP occurs in a region close to the CYP3As substrate recognition site 2 ([@b60-ehp-117-1541]). Alignments of amino acid sequences with all human CYP3A and the orthologs in rat (Cyp3a9) and mouse (Cyp3a13) by us indicated that the residue 192N is highly conserved (data not shown). It is possible that the N192S substitution affects the regioselectivity of CYP3A7 toward its substrates and thus is favored by natural selection. Interestingly, [@b37-ehp-117-1541] recently reported that a common nonsynonymous variant *CYP3A7\*2* is in strong LD with *CYP3A5\*1.* The *CYP3A7\*1*/*CYP3A5\*3* haplotype is associated with CYP3A7.1 expression but without CYP3A5 expression, whereas the *CYP3A7\*2*/*CYP3A5\*1* haplotype is associated with the expression of CYP3A5 and a more active form of CYP3A7 ([@b37-ehp-117-1541]). Unfortunately, however, we failed to identify the *CYP3A7\*2* variant in our study because of the highly homologous sequences of the *CYP3A* family, which prevented our addressing the possibility that *CYP3A7\*2* might be the target of positive selection.

One of the novel findings in our study was the unique natural selection pattern on *CYP3A43* in non-Africans. Most *CYP3A43* haplotypes in non-Africans contained the high frequency--derived alleles at G83448A and C83643T polymorphic sites. In addition, the *CYP3A43\*2* and *CYP3A43\*3* variants were also in significant LD with these SNPs in non-Africans. The skewed haplotype structure and significant result of haplotype diversity test suggest that the major haplotype in this region is favored by natural selection in non-Africans. The five variants that separated the two *CYP3A43* haplotype clusters had extremely high *F*~ST~ values for the Chinese--African and Caucasian--African comparisons, which also indicates the impact of population-specific selective pressures on *CYP3A43* in populations outside of Africa.

All neutrality tests showed significant departure from neutrality for the sequences from the *CYP3A5* exon 2 to the *CYP3A5* 3′ untranslated region in Caucasians. The remarkable interpopulation differences in both frequency spectrum and haplotype structure in *CYP3A5* also indicate a recent selective sweep in Caucasians, which is in accordance with the findings by [@b52-ehp-117-1541]. CYP3A5 is important in the metabolism of endogenous substrates such as cortisol and in environmental chemicals such as aflatoxin B~1~. *CYP3A5\*3* reportedly undergoes strong selective pressure (e.g., salt sensitivity) ([@b52-ehp-117-1541]). Other selective pressures, especially from dietary chemical exposure, may also play a role in shaping the unusual nucleotide diversity patterns in *CYP3A5* in Caucasians.

It has become clear that populations and individuals have their own individual finger-print of unique allelic architecture coding the xenobiotic response system, and these genetic variants have functional relevance with respect to drug response and environmentally related diseases ([@b33-ehp-117-1541]). Drug-metabolizing enzyme (DME) genes are among the most favorable targets of natural selection for their role in metabolism of environmental compounds. Recent genome-wide analyses indicate that the human xeno biotic metabolism and disposition system may have undergone unique natural selection ([@b39-ehp-117-1541]). It has also been shown in candidate gene--based studies that positive selection has acted on DME genes such as *CYP1A2* ([@b59-ehp-117-1541]), *CYP3A4* and *CYP3A5* ([@b41-ehp-117-1541]; [@b52-ehp-117-1541]), and *FMO3* (flavin-containing mono-oxygenase 3) ([@b2-ehp-117-1541]), all phase I DME genes; *NAT2* (*N*-acetyltransferase 2) ([@b35-ehp-117-1541]) and *UGT2B17* (UDP-glucuronosyltransferase 2 family, polypeptide B17) ([@b61-ehp-117-1541]), both phase II DME genes; *ABCB1* \[ATP-binding cassette, subfamily B, member 1; also named multidrug resistance 1 (*MDR1*)\] ([@b51-ehp-117-1541]; [@b54-ehp-117-1541]), and *ABCC1* ([@b55-ehp-117-1541]), both phase III DMEs. Among these genes, *CYP3A* and *ABCB1* are very interesting outliers because of their unique genetic and biochemical properties. The *CYP3A* gene cluster is located at chromosome 7, just 119 kb away from the *ABCB1* locus, which codes MDR1 (P-glycoprotein), the best-characterized phase III drug transporter and one of the major determinants of the absorption, distribution, metabolism, and excretion/toxicologic profiles for a large range of hydro phobic exogenous substrates, including nearly every category of clinically important drugs, with a substrate spectrum similar to that of CYP3A enzymes. In the liver, lung, kidney, and intestine, there is a close correlation between the expressions of CYP3A4 and ABCB1 and their transcriptional factor, the pregnane X receptor ([@b30-ehp-117-1541]), which coordinately regulates xenobiotic/drug metabolism and efflux through *trans*-activating the expression of the two genes ([@b49-ehp-117-1541]). We and other groups have previously reported positive selection on functional derived variants of *ABCB1* in its coding and regulatory regions in human populations, which are correlated with increased expression and enhanced transporter activity ([@b51-ehp-117-1541]; [@b54-ehp-117-1541]). The selection hotspot on the two closely linked major xenobiotic response genes, *CYP3A* and *ABCB1*, superimposed with their closely linked genomic map, their finely coordinated *trans*-activation for xenobiotic disposition and clearance, and their overlapping tissue expression profile and substrate spectrum, may provide a good model in evolutionary environmental medicine to decipher the integral and dynamic profile of the organization, function, and evolution of the xenobiotic disposition system.

In summary, this evolutionary population genetics study on the human *CYP3A* locus confirmed the previously reported positive selection on *CYP3A5* in non-Africans, revealed that *CYP3A4* and *CYP3A7* are under a recent or ongoing positive natural selection in the general human population, and also pointed to positive natural selection on *CYP3A43* in non-Africans. The complex pattern of natural selection on the allelic structure of the *CYP3A* locus may underlie the phenotypic variation in CYP3A activity in populations from different geographic regions and having inter-ethnic differences in response to drugs and herbal medicine as well as ethnic differences in predisposition to complex disorders resulting from CYP3A-substrate exposure.

Supplemental Material is available online (doi:10.1289/ehp.0800528.S1 via <http://dx.doi.org/>).
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![Genomic structure of genes and pseudogenes at the *CYP3A* locus. Abbreviations: Cen, centromere; Qtel, telomere. Exons for genes and pseudogenes are shown as boxes; arrows indicate transcriptional orientation; and broken lines indicate resequenced regions.](ehp-117-1541f1){#f1-ehp-117-1541}

![Frequency spectrum of derived alleles at the *CYP3A* locus in Chinese, Caucasians, and Africans. The expected frequency spectrum has been reported by [@b56-ehp-117-1541]; at the neutral equilibrium, the expected number of SNP sites at which the derived allele is present *i* times in the sample is given by 4*Nv/i*, where *N* and *v* are the effective population size and mutation rate, respectively. The formula to estimate 4*Nv* is the number of observed segregating sites divided by (1 + 1/2 + 1/3 + . . . + 1/*n*−1), where *n* is the number of chromosomes in each population.](ehp-117-1541f2){#f2-ehp-117-1541}

![Sliding-window neutrality tests of *CYP3A* locus. Each window contains 20 variations, with a step size of one variation. The midpoint variations at the 20th, 40th, 60th, 80th, 100th, 120th, 140th, and 160th sites are T88726C, T116513G, C147742T, A169228G, G186731A, A211137T, T251839A, and T270403C, respectively (as shown in [Table 1](#t1-ehp-117-1541){ref-type="table"}). Circles indicate significant values for corresponding neutrality tests.](ehp-117-1541f3){#f3-ehp-117-1541}

![LD structures at the *CYP3A* locus in Chinese (*A*), Caucasians (*B*), and Africans (*C*) as indicated by pairwise LD between variations, with minor allele frequency \> 5%, measured by \|D'\|. Haplotype blocks partitioned in each population are also shown to the right of corresponding LD structures.](ehp-117-1541f4){#f4-ehp-117-1541}

![Haplotype in the region between SNPs A73018G and G106490T in *CYP3A43* and MST of the haplotypes. (*A*) Haplotypes and their estimated frequencies in each population, including the ancestral haplotype in chimpanzee (Chimp). (*B* ) MST of the haplotypes in this region: one main cluster with only one common haplotype (left) and one minor cluster containing haplotypes of low or intermediate frequency (right). The size of each node is proportional to haplotype frequency in all three populations, and the frequency of each haplotype within each subpopulation is indicated by various shades within each node. Branches represent one nucleotide substitution, unless noted in parentheses.](ehp-117-1541f5){#f5-ehp-117-1541}

###### 

Nucleotide diversity and neutrality tests for the entire *CYP3A* locus.

  Summary statistic                                              Chinese                                               Caucasians                                            Africans                                              Non-Africans                                          Overall
  -------------------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------- -----------------------------------------------------
  Sample size                                                    29                                                    24                                                    24                                                    48                                                    77
  No. of segregating sites                                       57                                                    60                                                    113                                                   91                                                    167
  No. of singletons                                              32                                                    29                                                    42                                                    42                                                    74
  π (× 10^−4^)                                                   1.6                                                   1.4                                                   4.0                                                   1.5                                                   2.6
  θ~W~ (× 10^−4^)                                                2.8                                                   3.1                                                   5.8                                                   3.9                                                   6.8
  θ~H~ (× 10^−4^)                                                3.5                                                   4.5                                                   5.6                                                   5.1                                                   6.8
  D%[a](#tfn1-ehp-117-1541){ref-type="table-fn"}                 0.97                                                  0.95                                                  0.97                                                  0.95                                                  0.94
  Tajima's *D*                                                   −1.47[\*](#tfn2-ehp-117-1541){ref-type="table-fn"}    −1.96[\*](#tfn2-ehp-117-1541){ref-type="table-fn"}    −1.084                                                −1.98[\*](#tfn2-ehp-117-1541){ref-type="table-fn"}    −1.99[\*](#tfn2-ehp-117-1541){ref-type="table-fn"}
  Fu and Li's *D*[\*](#tfn2-ehp-117-1541){ref-type="table-fn"}   −3.20[\*](#tfn2-ehp-117-1541){ref-type="table-fn"}    −2.21                                                 −1.344                                                −4.55[\*](#tfn2-ehp-117-1541){ref-type="table-fn"}    −11.10[\*](#tfn2-ehp-117-1541){ref-type="table-fn"}
  Fu and Li's *F*[\*](#tfn2-ehp-117-1541){ref-type="table-fn"}   −3.04[\*](#tfn2-ehp-117-1541){ref-type="table-fn"}    −2.52[\*](#tfn2-ehp-117-1541){ref-type="table-fn"}    −1.397                                                −3.97[\*](#tfn2-ehp-117-1541){ref-type="table-fn"}    −8.48[\*](#tfn2-ehp-117-1541){ref-type="table-fn"}
  Fay and Wu's *H*                                               −6.94                                                 −13.81[\*](#tfn2-ehp-117-1541){ref-type="table-fn"}   −5.42                                                 −15.61                                                −16.24
  HKA *p-*value                                                  0.01[\*\*](#tfn3-ehp-117-1541){ref-type="table-fn"}   0.01[\*\*](#tfn3-ehp-117-1541){ref-type="table-fn"}   0.01[\*\*](#tfn3-ehp-117-1541){ref-type="table-fn"}   0.01[\*\*](#tfn3-ehp-117-1541){ref-type="table-fn"}   0.01[\*\*](#tfn3-ehp-117-1541){ref-type="table-fn"}

Fixed sequence differences between human and chimpanzee.

*p* \< 0.05.

*p* \< 0.01.

###### 

Haplotype diversity test in *CYP3A43* and *CYP3A5* gene regions.

                *CYP3A43*   *CYP3A5*           
  ------------- ----------- ---------- ------- -------
  Chinese       0.257       0.002      0.547   0.226
  Caucasian     0.373       0.008      0.467   0.038
  African       0.860       0.531      0.801   0.663
  Non-African   0.310       0.004      0.518   0.055
  Overall       0.533       0.006      0.662   0.076
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